- Home
- FLGT vs RXST Comparison
FLGT vs RXST Comparison
Compare FLGT & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGT
- RXST
- Stock Information
- Founded
- FLGT 2011
- RXST 1997
- Country
- FLGT United States
- RXST United States
- Employees
- FLGT N/A
- RXST N/A
- Industry
- FLGT Medical Specialities
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FLGT Health Care
- RXST Health Care
- Exchange
- FLGT Nasdaq
- RXST Nasdaq
- Market Cap
- FLGT 587.3M
- RXST 553.1M
- IPO Year
- FLGT 2016
- RXST 2021
- Fundamental
- Price
- FLGT $18.07
- RXST $7.47
- Analyst Decision
- FLGT Buy
- RXST Hold
- Analyst Count
- FLGT 2
- RXST 12
- Target Price
- FLGT $24.00
- RXST $18.45
- AVG Volume (30 Days)
- FLGT 210.6K
- RXST 1.9M
- Earning Date
- FLGT 08-01-2025
- RXST 08-07-2025
- Dividend Yield
- FLGT N/A
- RXST N/A
- EPS Growth
- FLGT N/A
- RXST N/A
- EPS
- FLGT N/A
- RXST N/A
- Revenue
- FLGT $292,448,000.00
- RXST $148,310,000.00
- Revenue This Year
- FLGT $11.79
- RXST $17.41
- Revenue Next Year
- FLGT $10.45
- RXST $12.44
- P/E Ratio
- FLGT N/A
- RXST N/A
- Revenue Growth
- FLGT 1.71
- RXST 46.70
- 52 Week Low
- FLGT $14.57
- RXST $6.32
- 52 Week High
- FLGT $25.11
- RXST $58.23
- Technical
- Relative Strength Index (RSI)
- FLGT 29.01
- RXST 20.31
- Support Level
- FLGT $19.18
- RXST $6.32
- Resistance Level
- FLGT $19.96
- RXST $8.50
- Average True Range (ATR)
- FLGT 0.56
- RXST 0.70
- MACD
- FLGT -0.15
- RXST -0.55
- Stochastic Oscillator
- FLGT 0.86
- RXST 15.31
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.